Skip to main content

PerkinElmer Acquires Labtronics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer announced on Monday that it has acquired electronic lab notebook developer Labtronics for an undisclosed amount.

PerkinElmer said that the acquisition extends its electronic lab notebook and data integration software offerings into labs conducting strict routine procedures, such as regulated and non-regulated QA/QC, late-stage product or method development, and environmental and food testing.

The deal builds on PerkinElmer's recent acquisitions of CambridgeSoft and ArtusLabs, both of which expanded the firm's informatics capabilities. Two weeks ago, PerkinElmer also announced it had acquired genetic analysis software firm Geospiza.

Dusty Tenney, president of analytical sciences and laboratory services for PerkinElmer, said that the acquisition enhances the firm's "strategic focus on enterprise-wide knowledge sharing and access." He added that the acquired products also present "strong synergies" with its OneSource Laboratory Services portfolio.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.